Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Sensitive Tuberculosis”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Testing effectiveness (Phase 2)Study completedNCT01241188
What this trial is testing

A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB)

Who this might be right for
Tuberculosis
Statens Serum Institut 253
Not applicableNot Yet RecruitingNCT07164742
What this trial is testing

Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)

Who this might be right for
TB - TuberculosisTBTB Infection
Johns Hopkins University 690
Not applicableActive Not RecruitingNCT05840809
What this trial is testing

Pharmacokinetics of Drugs Used to Treat Drug Sensitive Tuberculosis in Breastfeeding Mother-infant Pairs

Who this might be right for
Tuberculosis ActiveBreastfeedingTuberculosis
University of Liverpool 20
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Testing effectiveness (Phase 2)Study completedNCT02381470
What this trial is testing

Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers

Who this might be right for
Pulmonary Tuberculosis
National University Hospital, Singapore 58
Testing effectiveness (Phase 2)Study completedNCT01225640
What this trial is testing

PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay

Who this might be right for
Tuberculosis
Sequella, Inc. 59
Testing effectiveness (Phase 2)Study completedNCT02619994
What this trial is testing

Treatment Shortening of MDR-TB Using Existing and New Drugs

Who this might be right for
Tuberculosis, Multidrug-Resistant
Seoul National University Hospital 214
Testing effectiveness (Phase 2)Study completedNCT02193776
What this trial is testing

To Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.

Who this might be right for
Tuberculosis
Global Alliance for TB Drug Development 240
Large-scale testing (Phase 3)Looking for participantsNCT07209761
What this trial is testing

Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 532
Large-scale testing (Phase 3)Looking for participantsNCT05401071
What this trial is testing

Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)

Who this might be right for
Tuberculosis, Pulmonary
Huashan Hospital 2,442
Testing effectiveness (Phase 2)Study completedNCT01936831
What this trial is testing

High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)

Who this might be right for
Tuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 282
Not applicableNot Yet RecruitingNCT06921278
What this trial is testing

Development of the Drug and Alcohol Respiratory Health Test

Who this might be right for
Respiratory DiseaseSubstance-Related DisordersCOPD+6 more
King's College London 260
Testing effectiveness (Phase 2)UnknownNCT05926466
What this trial is testing

BTZ-043 Dose Evaluation in Combination and Selection

Who this might be right for
Tuberculosis, PulmonaryOther Specified Pulmonary Tuberculosis
Michael Hoelscher 90
Large-scale testing (Phase 3)Not Yet RecruitingNCT04485156
What this trial is testing

Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)

Who this might be right for
Tuberculosis, Pulmonary
Seoul National University Hospital 926
Testing effectiveness (Phase 2)Active Not RecruitingNCT06058299
What this trial is testing

Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis

Who this might be right for
Pulmonary TBPulmonary TuberculosisDrug Sensitive Tuberculosis
Global Alliance for TB Drug Development 309
Testing effectiveness (Phase 2)Study completedNCT04044001
What this trial is testing

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Who this might be right for
Pulmonary TuberculosesOther Specified Pulmonary Tuberculosis
Michael Hoelscher 77
Testing effectiveness (Phase 2)Study completedNCT03563599
What this trial is testing

Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)

Who this might be right for
Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB
Qurient Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Large-scale testing (Phase 3)Study completedNCT03338621
What this trial is testing

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 455
Load More Results